文献速递甲状腺核医学核素与放射性配体治疗

良性膈肌间皮囊肿在治疗后SPECT/CT上表现为碘-131摄取,模拟甲状腺癌转移

I-131 Uptake in a Benign Diaphragmatic Mesothelial Cyst Mimicking Thyroid Cancer Metastasis on Post-therapy SPECT/CT.
PubMed 文献 · Clin Nucl Med · 2025-07-01

一例33岁女性甲状腺癌全切除术后行碘-131治疗,治疗后SPECT/CT发现膈肌间皮囊肿处 incidental 碘-131摄取,经肝脏MRI和切除活检均排除甲状腺癌转移,提示识别良性碘摄取来源可避免不必要干预。

要点

  • 甲状腺癌碘-131治疗后SPECT/CT可偶见良性囊肿摄取,模拟转移灶。
  • 膈肌间皮囊肿可表现为碘-131假阳性摄取,需进一步影像或活检鉴别。
  • 识别良性碘摄取来源有助于避免不必要的干预。

核心结论

  • 良性膈肌间皮囊肿可在碘-131治疗后SPECT/CT上表现为假阳性摄取,模拟甲状腺癌转移。

研究设计与样本

  • 病例报告:一例33岁女性,行全甲状腺切除术后接受碘-131放射性碘治疗。

主要发现

  • 治疗后SPECT/CT显示膈肌间皮囊肿处偶发碘-131摄取。
  • 后续肝脏MRI和切除活检均阴性,排除甲状腺癌转移。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radioiodine ablation therapy is commonly used for patients with well-differentiated thyroid cancer. False-positive radioiodine uptake in benign cystic lesions on post-therapy SPECT/CT presents a recognized diagnostic challenge. Here, we present the case of a 33-year-old woman who underwent total thyroidectomy, followed by I-131 radioiodine therapy. Her post-I-131 therapy SPECT/CT revealed incidental radioiodine uptake in a diaphragmatic mesothelial cyst, prompting further investigation. She subsequently underwent a dedicated liver MRI and excision biopsy, both of which were negative for thyroid cancer metastasis. This case highlights the importance of identifying benign sources of radioiodine uptake to avoid unnecessary interventions.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Bilgin C, Belge Bilgin G, Dundar B, et al. I-131 Uptake in a Benign Diaphragmatic Mesothelial Cyst Mimicking Thyroid Cancer Metastasis on Post-therapy SPECT/CT. Clin Nucl Med. 2025. PMID: 40590084. doi:10.1097/RLU.0000000000005923

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。